Workflow
圣湘生物: 圣湘生物科技股份有限公司关于不再设置监事会、修订《公司章程》并办理工商变更登记及制定、修订部分治理制度的公告

Core Viewpoint - The company has decided to abolish the supervisory board and amend its articles of association to enhance corporate governance and compliance with relevant laws and regulations [1][2]. Summary by Sections Abolishment of Supervisory Board - The company will no longer have a supervisory board, with its functions being transferred to the audit committee under the board of directors [1]. - This decision is in line with the provisions of the Company Law and aims to improve the company's governance structure [1][2]. Amendments to Articles of Association - The company plans to revise its articles of association to reflect the changes in governance structure and ensure compliance with the latest legal requirements [2]. - Key amendments include: - The definition of the company and its stakeholders has been broadened to include employees [2]. - The legal representative of the company will now be the director representing the company in executing its affairs [2]. - The total number of shares issued by the company remains at 579,388,006 [3]. - The company will not provide financial assistance for the acquisition of its shares, except for employee stock ownership plans [3]. Governance and Compliance - The company emphasizes the importance of adhering to the latest laws and regulations to enhance its governance level [2]. - The audit committee will now assume the supervisory functions previously held by the supervisory board, ensuring continued oversight of the company's operations [1][2].